Literature DB >> 26015276

Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients.

Tadashi Yamamoto1, Shigeichi Shoji2, Tomoyuki Yamakawa2, Atsushi Wada3, Kazuyuki Suzuki3, Kunitoshi Iseki3, Yoshiharu Tsubakihara3.   

Abstract

BACKGROUND: To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. STUDY
DESIGN: An observational study including cross-sectional and 1-year analyses. SETTING &amp; PARTICIPANTS: Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. PREDICTOR: Predialysis pH<7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH<7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). OUTCOMES: All-cause and cardiovascular (CV) mortality during the 1-year follow-up. MEASUREMENTS: HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate.
RESULTS: Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH≥7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH<7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH≥7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. LIMITATIONS: Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths.
CONCLUSIONS: Predialysis pH≥7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Japanese Renal Data Registry (JRDR); Predialysis pH; acid-base status; all-cause mortality; cardiovascular mortality; dialysate bicarbonate; end-stage renal disease (ESRD); hemodialysis; metabolic acidosis; postdialysis pH; renal replacement therapy; serum bicarbonate

Mesh:

Substances:

Year:  2015        PMID: 26015276     DOI: 10.1053/j.ajkd.2015.04.014

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

1.  Metabolic acidosis status and mortality in patients on the end stage of renal disease.

Authors:  Vaia D Raikou
Journal:  J Transl Int Med       Date:  2016-12-30

Review 2.  Bicarbonate Balance and Prescription in ESRD.

Authors:  Matthew K Abramowitz
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

Review 3.  Carbon dioxide: Global warning for nephrologists.

Authors:  Marco Marano; Anna D'Amato; Alessandra Cantone
Journal:  World J Nephrol       Date:  2016-09-06

Review 4.  Epidemiology of Acid-Base Derangements in CKD.

Authors:  Wei Chen; Matthew K Abramowitz
Journal:  Adv Chronic Kidney Dis       Date:  2017-09       Impact factor: 3.620

5.  Temporal Changes in Electrolytes, Acid-Base, QTc Duration, and Point-of-Care Ultrasound during Inpatient Hemodialysis Sessions.

Authors:  Katherine Scovner Ravi; Caroline Espersen; Katherine A Curtis; Jonathan W Cunningham; Karola S Jering; Narayana G Prasad; Elke Platz; Finnian R Mc Causland
Journal:  Kidney360       Date:  2022-05-10

6.  Case in Point: Correction of Dialysis-Induced Metabolic Alkalosis.

Authors:  Assad Mohammedzein; Tarek Naguib
Journal:  Fed Pract       Date:  2021-04

Review 7.  Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2018-06-12       Impact factor: 4.546

8.  Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.

Authors:  Ekamol Tantisattamo; Victoria Murray; Yoshitsugu Obi; Christina Park; Christina J Catabay; Yuji Lee; Cachet Wenziger; Jui-Ting Hsiung; Melissa Soohoo; Carola-Ellen Kleine; Connie M Rhee; Jeffrey Kraut; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Am J Nephrol       Date:  2021-04-23       Impact factor: 3.754

9.  Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis.

Authors:  Danielle Creme; Kieran McCafferty
Journal:  Int J Nephrol       Date:  2015-09-20

10.  The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.

Authors:  William B Smith; Sandy Gibson; George E Newman; Kendra S Hendon; Margarita Askelson; James Zhao; Jamil Hantash; Brigid Flanagan; John W Larkin; Len A Usvyat; Ravi I Thadhani; Franklin W Maddux
Journal:  BMC Nephrol       Date:  2017-08-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.